Oral administration of dibenzoylmethane (DBM) prevents cognitive decline in a C9ORF72-mediated FTD mouse model
Paulina Torres, Daniela Becerra, José I. Astorga, Matías Fuentealba, Grant Kauwe, Luis Gonzalez, Guillermo Diaz, Vania Morales, Vicente Valenzuela, Cameron Wehrfritz, Yani Y. Ngwala, Claudia Sepúlveda-Quiñenao, Samah Shah, Joanna Bons, Leonard Petrucelli, , Claudio A. Hetz
This study shows that oral DBM treatment prevents cognitive decline in a C9ORF72 FTD mouse model without altering protein inclusions but corrects gene expression changes related to cytoskeleton, ALS, and metabolism.
bioRxiv · Aug 10, 2026 · PreprintMolecular Biology